These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 2850412
1. The relationship of receptor occupancy to the kinetics of cell death mediated by tumor necrosis factor. Coffman FD, Green LM, Ware CF. Lymphokine Res; 1988; 7(4):371-83. PubMed ID: 2850412 [Abstract] [Full Text] [Related]
2. Cytotoxicity mediated by tumor necrosis factor in variant subclones of the ME-180 cervical carcinoma line: modulation by specific inhibitors of DNA topoisomerase II. Coffman FD, Green LM, Godwin A, Ware CF. J Cell Biochem; 1989 Feb; 39(2):95-105. PubMed ID: 2541144 [Abstract] [Full Text] [Related]
4. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma. Andrews JS, Berger AE, Ware CF. J Immunol; 1990 Apr 01; 144(7):2582-91. PubMed ID: 1969453 [Abstract] [Full Text] [Related]
5. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells. Kircheis R, Milleck J, Korobko VG, Shingarova LN, Schmidt HE. Eur Cytokine Netw; 1992 Apr 01; 3(4):381-90. PubMed ID: 1330049 [Abstract] [Full Text] [Related]
7. Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line. Vanhaesebroeck B, Van Bladel S, Lenaerts A, Suffys P, Beyaert R, Lucas R, Van Roy F, Fiers W. Cancer Res; 1991 May 01; 51(9):2469-77. PubMed ID: 1849793 [Abstract] [Full Text] [Related]
8. Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C. Byun HS, Park KA, Won M, Yang KJ, Shin S, Piao L, Kwak JY, Lee ZW, Park J, Seok JH, Liu ZG, Hur GM. Mol Pharmacol; 2006 Sep 01; 70(3):1099-108. PubMed ID: 16798936 [Abstract] [Full Text] [Related]
9. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors. Kost ER, Mutch DG, Herzog TJ. Gynecol Oncol; 1999 Mar 01; 72(3):392-401. PubMed ID: 10053112 [Abstract] [Full Text] [Related]
14. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. Lantz M, Gullberg U, Nilsson E, Olsson I. J Clin Invest; 1990 Nov 01; 86(5):1396-1402. PubMed ID: 2173717 [Abstract] [Full Text] [Related]
17. Characterization of the in vitro and in vivo species preference of human and murine tumor necrosis factor-alpha. Kramer SM, Aggarwal BB, Eessalu TE, McCabe SM, Ferraiolo BL, Figari IS, Palladino MA. Cancer Res; 1988 Feb 15; 48(4):920-5. PubMed ID: 2827889 [Abstract] [Full Text] [Related]
18. The TNF receptor in TNF-mediated cytotoxicity. Kull FC. Nat Immun Cell Growth Regul; 1988 Feb 15; 7(5-6):254-65. PubMed ID: 2851740 [Abstract] [Full Text] [Related]
19. Calcium-independent pathway of tumor necrosis factor-mediated lysis of target cells. Hasegawa Y, Bonavida B. J Immunol; 1989 Apr 15; 142(8):2670-6. PubMed ID: 2495322 [Abstract] [Full Text] [Related]